Sees FY25 LINZESS U.S. sales $800M-$850M. Sees FY25 adjusted EBITDA greater than $85M.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.